|
gptkbp:instanceOf
|
gptkb:drug
gptkb:opioid
|
|
gptkbp:administeredBy
|
oral
intramuscular injection
subcutaneous injection
|
|
gptkbp:ATCCode
|
gptkb:N02AA08
|
|
gptkbp:brand
|
gptkb:DHC_Continus
gptkb:Dico
Codhydrone
DF118
Dihydrin
Dihydrocodeine Tartrate
Drocode
Paracodin
Synalgos DC
Tussipax
|
|
gptkbp:broadcastOn
|
Schedule 5 (UK)
Schedule II (US, when in single ingredient form)
Schedule III (US, in combination products)
|
|
gptkbp:CASNumber
|
125-28-0
|
|
gptkbp:chemicalFormula
|
C18H23NO3
|
|
gptkbp:contraindication
|
acute asthma
paralytic ileus
respiratory insufficiency
|
|
gptkbp:developedBy
|
gptkb:Germany
|
|
gptkbp:developedYear
|
1911
|
|
gptkbp:discoveredBy
|
gptkb:Georg_Merck
|
|
gptkbp:eliminationHalfLife
|
3.5-5 hours
|
|
gptkbp:excretion
|
kidneys
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:MeSH_ID
|
D003707
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:pregnancyCategory
|
C (US)
B3 (Australia)
|
|
gptkbp:PubChem_CID
|
CHEMBL1201207
DB00454
5362440
|
|
gptkbp:relatedTo
|
gptkb:codeine
gptkb:morphine
hydrocodone
|
|
gptkbp:riskFactor
|
addiction
respiratory depression
|
|
gptkbp:sideEffect
|
nausea
vomiting
constipation
dizziness
itching
drowsiness
|
|
gptkbp:UNII
|
L5W6D9P6LL
|
|
gptkbp:usedFor
|
pain management
cough suppression
dyspnea treatment
|
|
gptkbp:bfsParent
|
gptkb:Schedule_I_(UN_Single_Convention_on_Narcotic_Drugs)
gptkb:DHC_Oral_Syrup
|
|
gptkbp:bfsLayer
|
8
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Dihydrocodeine
|